| Date | Form | Description | Docs | XBRL | Pages |
| 08/24/17 | 8-K | Current report filing |
|
3 | |
| 08/18/17 | 8-K | Current report filing |
|
2 | |
| 08/08/17 | DEF 14A | Definitive proxy statements |
|
37 | |
| 07/25/17 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 07/25/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 07/21/17 | 8-K | Current report filing |
|
3 | |
| 07/12/17 | 8-K | Current report filing |
|
3 | |
| 06/22/17 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
5 | |
| 06/22/17 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
5 | |
| 06/06/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10
Read More...Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
Read More...Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
Read More...